Mifepristone: Additional Phase I/II data

Data from 13 evaluable patients with glucocorticoid receptor ( GCCR)-positive metastatic triple-negative breast cancer (TNBC) in an open-label, dose-escalation, U.S. Phase I/II trial showed that once...